Investor Relations

High-growth company with focus on becoming a single-use pure player within all main endoscopy markets.

Latest news

09

Sep. 2026

Major shareholder announcements

With reference to Section 30 of the Danish Capital Markets Act, Ambu A/S hereby announces that on 9 September 2026, Ambu A/S has received three separate major shareholder notifications regarding voting rights attached to A-shares in Ambu A/S from:

  • Dorrit Ragle
  • Kim Ragle, and
  • Anne-Mette Ragle

The three major shareholder announcements are published as appendices to this company announcement.

Read the full company announcement here.

Download relevant attachments here:

 

Company announcement no. 18 2025/26.

07

Sep. 2026

Transactions under Ambu's share buyback program

On 6 May 2026, Ambu announced a share buyback program (company announcement no. 12 2025/26). The share buyback program is carried out in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) (as amended) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016, also referred to as the Safe Harbor Regulations.                                                                                              

During the program, Ambu will repurchase shares for a total amount of up to DKK 300m from 6 May 2026 until no later than 30 September 2026. The repurchased shares are bought with the aim of completing a share capital decrease as set out in Article 5(2)(a) in MAR.  

The following transactions have been made under the program from 31 Aug 2026 to 04 Sept 2026: 

 

Number of shares 

Average purchase price, DKK Transaction value, DKK 
Accumulated under the program after last announcement 3,786,138 66.6631 252,395,712 
2026.08.31 16,000 71.3690 1,141,904 
2026.09.01 7,080 71.3353 505,054 
2026.09.02 5,926 70.4641 417,570 
2026.09.03 62,386 70.3256 4,387,335 
2026.09.04 221,209 68.5148 15,156,099 
Accumulated under the program 4,098,739 66.8507 274,003,673 

After the above disclosed transactions DKK 25,996,327 remains to be repurchased. Ambu now owns 8,248,350 treasury shares, corresponding to 3.1% of the share capital.

Download the company announcement here.

31

Aug. 2026

Transactions under Ambu's share buyback program

On 6 May 2026, Ambu announced a share buyback program (company announcement no. 12 2025/26). The share buyback program is carried out in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) (as amended) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016, also referred to as the Safe Harbor Regulations.

During the program, Ambu will repurchase shares for a total amount of up to DKK 300m from 6 May 2026 until no later than 30 September 2026. The repurchased shares are bought with the aim of completing a share capital decrease as set out in Article 5(2)(a) in MAR.

The following transactions have been made under the program from 24 Aug 2026 to 28 Aug 2026: 
 

 Number of shares Average purchase price, DKK Transaction value, DKK 
Accumulated under the program after last announcement3,563,395 66.2263235,990,312
2026.08.24 65,907 78.4461 5,170,148 
2026.08.25 60,000 78.1825 4,690,948 
2026.08.26 48,692 64.9337 3,161,751 
2026.08.27 1,000 67.8140 67,814 
2026.08.28 47,144 70.3109 3,314,739 
Accumulated under the program 3,786,138 66.6631 252,395,712 


After the above disclosed transactions DKK 47,604,288 remains to be repurchased. Ambu now owns 7,935,749 treasury shares, corresponding to 2.9% of the share capital.

Download the company announcement here.

Financial Reports

Get the latest annual & quarterly reports
Read more

Annual Key Figures

Get an overview of Ambu's key figures
Read more

Presentations

Get the latest investor presentations and webcasts
Read more

Upcoming events

26

Aug. 2026

Earnings release Q3 2025/26

30

Sep. 2026

End of fiscal year 2025/26

05

Nov. 2026

Annual report 2025/26

News from Ambu

Sign up and receive news and company announcements from Ambu

Sign up

 

keyboard_arrow_up
close

Health Care Professionals

Text

Text

Text

Text

Text

Text